Waters Corporation (NYSE:WAT) has been assigned a consensus rating of “Hold” from the seventeen research firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $192.17.

WAT has been the topic of a number of recent research reports. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $211.00 target price on the stock in a research note on Monday, October 23rd. Morgan Stanley raised Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 target price on the stock in a research note on Monday, December 4th. Barclays upped their target price on Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 25th. Deutsche Bank upped their target price on Waters from $199.00 to $200.00 and gave the company a “hold” rating in a research note on Wednesday, October 25th. Finally, Cowen reaffirmed a “hold” rating and issued a $190.00 target price on shares of Waters in a research note on Friday, November 3rd.

Shares of Waters (WAT) opened at $196.56 on Monday. The firm has a market capitalization of $15,630.00, a P/E ratio of 27.30, a P/E/G ratio of 2.85 and a beta of 0.82. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. Waters has a fifty-two week low of $133.71 and a fifty-two week high of $201.95.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.03. The business had revenue of $565.58 million for the quarter, compared to analysts’ expectations of $555.25 million. Waters had a return on equity of 23.61% and a net margin of 24.34%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.57 EPS. analysts expect that Waters will post 7.42 earnings per share for the current year.

In other Waters news, SVP Rohit Khanna sold 26,913 shares of the stock in a transaction on Friday, October 27th. The stock was sold at an average price of $197.93, for a total transaction of $5,326,890.09. Following the transaction, the senior vice president now owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Eugene G. Cassis sold 23,863 shares of the stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $197.53, for a total value of $4,713,658.39. Following the transaction, the senior vice president now directly owns 15,100 shares in the company, valued at approximately $2,982,703. The disclosure for this sale can be found here. In the last three months, insiders have sold 69,776 shares of company stock worth $13,798,343. Corporate insiders own 5.07% of the company’s stock.

Several institutional investors have recently modified their holdings of the business. Parametric Portfolio Associates LLC lifted its stake in shares of Waters by 6.4% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 166,698 shares of the medical instruments supplier’s stock worth $29,926,000 after purchasing an additional 10,015 shares during the period. IFM Investors Pty Ltd purchased a new position in shares of Waters in the 3rd quarter worth $398,000. Bares Capital Management Inc. raised its position in shares of Waters by 0.6% in the 3rd quarter. Bares Capital Management Inc. now owns 728,948 shares of the medical instruments supplier’s stock worth $130,861,000 after buying an additional 4,663 shares during the period. California Public Employees Retirement System raised its position in shares of Waters by 6.6% in the 3rd quarter. California Public Employees Retirement System now owns 207,968 shares of the medical instruments supplier’s stock worth $37,334,000 after buying an additional 12,868 shares during the period. Finally, Janney Montgomery Scott LLC purchased a new position in shares of Waters in the 3rd quarter worth $459,000. 92.29% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at https://www.watchlistnews.com/waters-corporation-wat-given-average-recommendation-of-hold-by-analysts/1770585.html.

About Waters

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Analyst Recommendations for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.